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Abstract
An increasing number of reports indicate successful use of dental implants (DI) during
oral rehabilitation for head and neck cancer patients undergoing tumor surgery and
radiation therapy. Implant-supported dentures are a viable option when patients cannot
use conventional dentures due to adverse effects of radiation therapy, including oral
dryness or fragile mucosa, in addition to compromised anatomy; however, negative ef-
fects of radiation, including osteoradionecrosis, are well documented in the literature,
and early loss of implants in irradiated bone has been reported. There is currently no
consensus concerning DI safety or clinical guidelines for their use in irradiated head and
neck cancer patients. It is important for health care professionals to be aware of the mul-
tidimensional risk factors for these patients when planning oral rehabilitation with DIs,
and to provide optimal treatment options and maximize the overall treatment outcome.
This paper reviews and updates the impact of radiotherapy on DI survival and discusses
clinical considerations for DI therapy in irradiated head and neck cancer patients.
Cancer of the oral cavity and pharynx, the largest group of
head and neck cancers, is the ninth most common cancer in
males in the United States.1 Approximately 40,000 people will
be newly diagnosed with oral cancer with a 5-year survival
rate of 57%.2 Surgery is a well-established treatment and may
include radiotherapy (RT) and/or chemotherapy.3 Reconstruc-
tion of major surgical defects is required for a majority of the
cases, followed by rehabilitation of missing teeth and restoring
orofacial function.
Use of implants for prosthetic reconstruction has dramati-
cally increased due to advancements in materials science and
surgical techniques during the past three decades.4 Implant-
supported dentures seem to be a viable option, especially when
RT’s adverse effects, such as oral dryness or fragile mucosa,
along with compromised anatomy, hamper the use of conven-
tional removable dentures.5
An increased number of reports indicate successful implant-
supported prostheses in irradiated cancer patients.6-10 How-
ever, the negative effects of radiation are well documented,11
and several studies in both animals and humans have shown
an increased risk of early loss of dental implants (DI) in ir-
radiated bone.12-14 There is currently no consensus about the
predictability, safety, or clinical guidelines for DI therapy in
irradiated head and neck cancer patients. This paper reviews
the impact of RT on DI therapy and discusses updated clinical
considerations for DI therapy in those patients.
RT and its adverse effects
Cancer cells are in a continuous state of mitosis. Ionizing radia-
tion produces energy that injures or destroys cells by damaging
nuclear DNA or altering the molecular characteristics of indi-
vidual cells.2 Most patients with head and neck cancer receive
between 50 and 70 Grays (Gy) as a curative dose. For con-
comitant use, 45 Gy are used preoperatively and 55 to 60 Gy
postoperatively. These doses are typically fractionated over a
period of 5 to 7 weeks, once a day, 5 days a week, with a daily
dose of approximately 2 Gy.2 Normally, each daily treatment
lasts about 10 to 15 minutes. Fractionated radiation is used be-
cause in general, normal tissue repairs sub-lethal DNA damage
better than tumor tissue, especially in the low-dose range.
Adverse effects of RT include mucositis, hyposalivation,
loss of taste, radiation caries, trismus, and osteoradionecrosis
(ORN) of the jaw. ORN, ischemic necrosis of bone, is one of the
most serious complications.11 Initial changes in bone caused by
irradiation result from direct injury to the remodeling system
(osteocytes, osteoblasts, and osteoclasts). In addition, vascular
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Figure 1 CT scan showing the fracture of the right mandible of a patient
after tumor surgery, RT, and HBO.
injury precedes hyperemia, followed by endarteritis, thrombo-
sis, and a progressive occlusion and obliteration of small ves-
sels. With time, the bone marrow exhibits marked acellularity
and avascularity, with marked fibrosis and fatty degeneration.14
ORN occurs in the mandible more often than the maxilla. Al-
though 30% of cases may be asymptomatic, more patients with
ORN present pain, fistula formation, and in more severe cases,
spontaneous bone fracture (Fig 1). Recent systematic reviews
found the risk of developing ORN in irradiated head and neck
cancer patients as low as 2%; however, the risk can be higher af-
ter tooth extraction.15,16 While peak time of spontaneous ORN
was in the first 2 to 3 years after RT,17 the risk of trauma-induced
ORN might last indefinitely.11 The risk and severity of ORN is
known to be directly related not only to radiation dose and the
volume of irradiated tissue, but also to the dental health of the
patients.15
RT on implant survival
Many studies have shown that DI therapy in irradiated patients
is not significantly less favorable than in the non-irradiated pop-
ulation (Table 1). These studies were identified via a PubMed
search using Medical Subject Headings and keyword phrases
for “dental implants,” “dental prosthesis,” “radiotherapy,” “ra-
diation effects,” and other variations. The papers were limited
to human studies, English language papers, and papers pub-
lished since 2000. Clinical reports and studies with a sample
size less than 10 were excluded. The identified studies reported
implant survival rates or success rates in patients with RT rang-
ing from 74.4% to 98.9% with the majority reporting survival
rates above 84%. Many additional studies also reported high
function of implant-supported dentures in irradiated head and
neck patients, with relatively high implant survival rates.18-20
However, conflicting results exist. The major concerns for DI
therapy in irradiated head and neck cancer patients are the po-
tential for delayed healing and the later risk of ORN.21,22 In
a recent review of the literature evaluating RT effects on both
dental and craniofacial implants in animal and human subjects,
the relative risk of implant failure in irradiated bone was found
to be 2 to 3 times greater than that of non-irradiated subjects.23
Animal models have revealed compromised osseointegration
of DI due to irradiation, such as impaired osteogenesis, bone
strength reduction, and significant fibrosis of the periosteum,
to be the common end-stage of tissue injury.13,24,25 Some hu-
man studies show a lower survival rate of implants placed in
irradiated bone compared to non-irradiated controls.1,9,12 The
differing methodologies among these studies, the varying def-
initions of implant survival and success, the improvements in
implant surface features, and variations in treatment modalities
may account for the controversies regarding DI predictability
in these patients.26-31 Many factors influencing treatment out-
come have been suggested (Fig 2). In the following section, we
will discuss the impact of RT on DI therapy.
Impact of RT on DI therapy
Radiation dose and implant location
DI failures were seldom seen at cumulative doses less than 45
Gy32 and more commonly seen at doses greater than 65 Gy.33
ORN risk has been reported to be highest in the extraction of
mandibular teeth within the radiation field with doses greater
than 60 Gy.7 Studies have shown that short survival of implants
in irradiated patients was significant with total doses >50 to 55
Gy.9,22,33 Many agree that DI survival in patients treated with
cumulative RT doses lower than 50 Gy can be comparable to
that in non-irradiated patients.34-36
Implants in the mandible have shown higher survival rates
than those in the maxilla.34,37 As mirrored by DI practice in
the general population,31 that is most likely due to high bone
density of the mandible providing better initial primary implant
stability. Visch et al, in their study with 130 consecutive can-
cer patients irradiated orally over a period of up to 14 years,
found implant location in the maxilla or mandible (59% and
85%, respectively) as a dominant factor (p = 0.001) among
other potential factors influencing implant survival.22 Nelson
et al reported similar results in the maxilla and mandible (70%
and 92%, respectively) in their first 5 years of follow-up, though
long-term survival rates (after 8 years) were found to be equivo-
cal.28 The region of the mandible anterior to the mental foramen
is usually exposed to a lower dose than other sites during RT
and seems to have better remodeling capability due to additional
vascular supply from the facial artery.38,39 It must be noted that
the radiation dose per implant site ideally should be known to
determine the impact of radiation dose on implant survival.4
However, it is often not available in the literature.23,40
RT modalities and adjuvant chemotherapy
Advancements in RT techniques have been developed to pre-
serve function of normal tissue and enhance tumor control.
Those include Intensity-Modulated Radiation Therapy (IMRT)
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Dental implant (DI) therapy-related  
•Timing of implant inseron 
•Integraon period 
•Anatomical sites of inseron
•Types of the ssue - bed
•Implant diameter, length
•Type of restoraon, prosthec design 
•Loading paern
Radiaon therapy (RT) - related  
•Radiaon dosage 
•Radiaon modality 
•Adjunct hyperbaric oxygen therapy  
•Conjuncve chemotherapy 
•Adverse eﬀects of RT 
Paent-related  
•Smoking 
•Comorbidies aﬀecng bone qualies and healing 
•Parafunconal habits (Bruxism /clenching )
•Occlusal stability
•Oral hygiene , Periodontal condion 
•Psychological status 
•Tumor - magnitude of surgery, prognosis
Figure 2 Potential factors impacting dental implant therapy in irradiated head and neck cancer patients.
and altered fractionation schedules (hyperfractionation and ac-
celerated fractionation). IMRT is a computer-driven technology
using rapid radiation beams of varying intensity to confine the
dose to the target tissues.41 IMRT in the head and neck region
aims to preserve the parotid glands particularly, resulting in pre-
vention of hyposalivation. Hyposalivation frequently results in
dental caries and necessitates tooth extraction, which increases
the risk of ORN.16 Hyperfractionation delivers an increased
number of fractions and total dose with a smaller dose per frac-
tion. Accelerated fractionation provides radiation at a faster rate
of accumulation than that of standard fractionation, and with
a similar total dose to conventional RT.40 A recent systematic
review found that risk of ORN after tooth extraction in irra-
diated patients was reduced by accelerated fractionation with
dose reduction but elevated by hyperfractionation.16 However,
studies focusing on the impact of RT modality on DI survival
are scarce at this time.
Concomitant chemotherapy is often incorporated in cancer
therapy to augment the anti-tumor effect of RT. Major side ef-
fects include acute mucositis and altered taste, which can be
multiplied with RT; however, currently there is little evidence
that chemotherapy influences DI therapy.42 Nabil and Samman
did not find significantly increased ORN risk in patients receiv-
ing chemoradiotherapy.16
Adjunctive use of hyperbaric oxygen
therapy (HBO)
HBO has been used for a wide range of medical conditions
such as syphilis, multiple sclerosis, and myocardial infarc-
tion. It raises levels and diffusion of oxygen in local tis-
sue by inducing angiogenesis, increasing bone metabolism
(enhancing osteoblast repopulation and fibroblast function),
and stimulating collagen synthesis.11 Therefore, it is expected
that HBO increases the capacity to repair tissue damaged
by RT.
The protocol of HBO used after RT in the head and neck
region usually includes 20 to 30 sessions (lasting 90 minutes
each) prior and 10 minutes after tooth extraction or implant
placement, at a compression of 2.4 atmospheres absolute pres-
sure with 100% oxygen.43 Many support adjunctive use of HBO
to prevent and manage ORN, especially when the implant site
is irradiated with more than 50 Gy and shows clinical signs
of radiation damage.6,15,35 Better wound healing on the im-
plant site of the mandible was noted in irradiated patients who
received HBO therapy during the 3 to 7 year follow-up pe-
riod.44 Granstro¨m et al45 found significantly lower failure rates
of craniofacial implants including DI in HBO-treated patients
than those in the non-HBO-treated group (8.1% vs. 53.7%,
respectively); however, opinions conflict on the prophylactic
effect of HBO in reducing the risk of RT-induced ORN, and
it has not been universally accepted in dentistry. Studies have
shown that HBO could not enhance implant survival in irra-
diated mandibular bone.29,46 Limited accessibility and its high
costs in time and money might be concerns.46 HBO requires
approximately 1 month before tooth extraction, which may not
always be practical for symptomatic cases. Potential complica-
tions such as middle ear barotraumas and myopia must also be
taken into consideration, as well as contraindications including
uncontrolled COPD.46
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Timing of implant placement related to RT
Optimal timing of DI insertion-related RT has been debated.
Immediate implant insertion before RT, at the same time as
the ablative tumor surgery, is referred to as primary placement,
as opposed to secondary placement after RT. Primary place-
ment of implants aims at achieving osseointegration prior to
onset of the damaging effects of RT, and early oral rehabili-
tation by avoiding additional surgery.3,47 Overall cost can be
reduced; however, indications may be limited to low-grade tu-
mors. Computer-guided implant placement has recently been
introduced to improve identification of the ideal implant lo-
cation during surgery.48-50 Secondary placement of implants
is probably more common in dental practice because primary
placement is not always available to patients in the hospital
setting. Delayed DI placement enables assessment of the post-
surgical status of the patients (both functionally and psycho-
logically), and more accurate cancer prognosis.29 Patients will
be given more time to choose prosthetic treatment options after
their recovery from tumor therapy and prior to initiation of an
extensive dental procedure.24
Recent publications have demonstrated encouraging results
in primary placement of DI.3,47 A human study shows bet-
ter implant survival in primary placement than in secondary
placement in edentulous mandibles of patients with oral squa-
mous cell carcinoma.3 However, a recent systematic review by
Colella et al found a similar implant failure rate between the
two groups (3.2% vs. 5.4%, respectively).32 Choice of implant
insertion timing (before RT vs. after RT) likely depends on
the surgical team’s personal preference.11 No randomized con-
trolled studies have been conducted regarding timing of implant
therapy and implant success.
How long should we wait for implant placement after RT?
The answer remains unclear at this time. Several studies showed
that 6 months after RT, DI survival was not affected by place-
ment timing.9,22 However, to avoid early complications of tu-
mor therapy, most clinicians agree to wait a minimum of 6 to
12 months.24 Others have recommended waiting a little longer
(12 to 18 months typically) to allow enough time for bone
remodeling and muscle healing.51,52 Tumor recurrence or de-
veloping a second malignancy in the adjacent region must be
another important consideration.34,53 The first 12 months after
tumor therapy is generally considered to be the high risk period
of recurrence. A longitudinal prospective study showed 44%
of cancer patients who underwent mandibular resection had
recurrence within 13 months of surgery.34
It must be noted that the risk of ORN may persist for years
after RT in head and neck cancer patients.4,14 Progressive loss
of capillaries (therefore loss of tissue perfusion) without evi-
dence of spontaneous revascularization over time was found in
a study by Marx and Johnson, using serial biopsy specimens
from more than 143 irradiated patient mandibles.14 Granstro¨m
et al reported progressive loss of DI due to failure of osseoin-
tegration up to 6 years after the placement.54
Oral health and psychological status of patients
related to RT
Although the direct impact of oral health status on DI survival
is not clear in the literature, local effects of RT on periodontal
tissue, and attachment loss particularly, have been reported in
several studies.55,56 Epstein et al observed tooth loss and pro-
gressive periodontal attachment loss in teeth within areas of
high-dose radiation.55 A study by Marques and Dib showed
similar results and explained that inadequate homecare result-
ing from lack of motivation, RT-induced hyposalivation, and
limited vertical opening might contribute to such significant
periodontal destruction in irradiated head and neck cancer pa-
tients.56 Poor oral health is known to increase ORN risk.57,58
Katsura et al reported that oral conditions such as periodontal
pocket depth >5 mm, dental plaque score >40%, and alveolar
bone loss >60%, in the first or second year after RT, as well
as smoking history after RT were significantly associated with
ORN risk.57
Patients undergoing cancer therapies are often weak. RT can
be detrimental to the patients’ quality of life, compromising
speech, swallowing, and sensory and masticatory function, in
addition to compromised esthetics caused by major surgery.11,29
After tumor therapies, patients often become apprehensive
about further extensive dental treatment, which results in un-
loaded implants.3,24 Compared to the high success rate of im-
plant osseointegration, a lower success rate for prostheses has
been reported.24 In the study by Smolka et al, prosthetic success
was reported as 42.9%, while implant success was 92% in 56
cancer patients who had mandibular free flap reconstruction.59
Schepers et al found the ultimate rates of functional implant-
supported dentures in the postoperative irradiated group versus
surgery-only group were 75.4% versus 75.6%, respectively,
compared to a 97% success rate of implant osseointegration
during the 23-month follow-up.3 In their study, 24.5% of the
primary-placed implants never became functional because of
cancer-related (tumor recurrence or metastasis) or psychologi-
cal reasons.
Discussion
Interpretation of published data needs special caution. Neither
a high implant survival rate nor success of osseointegration as-
sures functional DI or success of DI therapy in cancer patients;
however, with careful case selection, DI therapy in oral rehabil-
itation in irradiated head and neck cancer patients can be suc-
cessfully achieved. Before initiation of DI therapy, a patient’s
level of tolerance must be assured both physically and psycho-
logically. Reasonable oncologic prognosis should be obtained
from the physician. The planned implant site of the anterior
mandible and a cumulative radiation dosage lower than 50 Gy
may predict the outcome of DI therapy. If possible, consultation
with the radiation oncologist is encouraged to obtain radiation
dose distribution. A timespan of 12 months between the last
RT and implant insertion seems reasonable from both the on-
cologic and dental prospective; however, later complications of
RT, including ORN, are still not clear. In general, placement of
a minimal number of implants is recommended.2 It is the au-
thors’ opinion that options for primary placement of implants
should be discussed prior to tumor surgery to avoid potential
damage from RT for implant sites such as ORN. The impacts
of adjunctive HBO, chemotherapy, or RT modality on implant
survival remain uncertain.
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Throughout the oral rehabilitation, it is important to maintain
optimal periodontal health with appropriate management of
any adverse effects of RT. General known risk factors of DI
failure should be controlled to maximize the treatment outcome.
Lack of communication and education among the patient and
healthcare professionals have been raised as concerns.2 New
guidelines for prophylactic dental care prior to the head and
neck cancer treatment that could damage the oral tissue in
cancer patients are on the horizon.11,60
Conclusion
Multidimensional potential risk factors of DI failure must be
considered when planning DI therapy in irradiated head and
neck patients. Factors focusing on RT were discussed, and the
negative impacts of RT on DI therapy are undeniable. The
benefit of using implant-supported dentures over conventional
dentures must outweigh the risks. Meticulous treatment plan-
ning along with careful preoperative oral examination and good
coordination with oncologic specialists cannot be overempha-
sized. It is also important for the dental profession to keep
abreast of the latest available RT technologies. Additional
evidence-based clinical guidelines for implant use in head and
neck patients undergoing RT are expected.
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